Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
NCT05865054
This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
The research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and eyes. The target population includes patient with suspected giant cell arteritis (GCA; temporal arteritis).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Giant Cell Arteritis
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 50 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of Pennsylvania
- Last updated on ClinicalTrials.gov
- September 25, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Minnesota · 1
- Mayo Building and Gonda Building · Rochester, MN
Pennsylvania · 1
- 3400 Civic Center Blvd · Philadelphia, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.